Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CareView Communications (CRVW) Current Deferred Revenue (2019 - 2026)

CareView Communications' Current Deferred Revenue history spans 7 years, with the latest figure at $2.4 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue changed 0.13% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 million, a 0.13% change, with the full-year FY2025 number at $2.4 million, changed 0.13% from a year prior.
  • Current Deferred Revenue hit $2.4 million in Q4 2025 for CareView Communications, down from $3.1 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CRVW hit a ceiling of $3.5 million in Q2 2025 and a floor of $380415.0 in Q1 2021.
  • Historically, Current Deferred Revenue has averaged $1.8 million across 5 years, with a median of $1.5 million in 2022.
  • The widest YoY moves for Current Deferred Revenue: up 266.62% in 2022, down 9.46% in 2022.
  • Tracing CRVW's Current Deferred Revenue over 5 years: stood at $983667.0 in 2021, then fell by 9.46% to $890631.0 in 2022, then skyrocketed by 115.91% to $1.9 million in 2023, then rose by 25.53% to $2.4 million in 2024, then fell by 0.13% to $2.4 million in 2025.
  • Business Quant data shows Current Deferred Revenue for CRVW at $2.4 million in Q4 2025, $3.1 million in Q3 2025, and $3.5 million in Q2 2025.